Study to assess safety of a hormone therapy preparation containing Drospirenone/Estradiol in women with concomitant disease and medication known to potentate the risk of hyperkalemia
Please see attached Study Results Summary below.
No Inclusion Criteria Available
No Exclusion Criteria Available
A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety of the Hormone Replacement Therapy Combination Drug Product Drospirenone/Estradiol in Postmenopausal Women With Concomitant Disease and Medication Known to Potentiate the Risk of Hyperkalemia